In November 2013, more than 100 patients with cancer – including pancreatic, breast, liver and brain tumours – embarked on clinical trials involving BPM 31510, a drug discovered by an algorithm. The story of BPM 31510 begins with the extraction of biological data from healthy and cancerous tissue samples from over 1,000 patients. This data…
Tag: NAD+
NAD+ Update: Pathway linked to slower aging also fuels brain cancer
While a particular metabolic pathway shows potential to slow down the aging process, new research indicates a downside: That same pathway may drive brain cancer. The pathway, known as the nicotinamide adenine dinucleotide (NAD+) pathway, is overactive in a deadly form of brain cancer known as glioblastoma, according to a study by researchers at Washington…
Anti-aging Rapamycin drug update
CNN explores the decade of research on Rapamycin and its potential as anti-aging drug. It has been administered to dogs with good results and to a small number of human subjects. “It’s been remarkable,” Paola Anderson said as she watched Momo, her 13-year-old white Pomsky, run around the backyard, keeping up with dogs a third…
Helper molecule reverses degeneration of muscle in mouse model of tissue aging, wasting
Study illuminates role of essential compound in maintaining physical endurance, possible treatment Maintaining proper levels of an essential helper molecule is crucial for optimal muscle function, according to a study led by Joseph Baur, PhD, an assistant professor of Physiology in the Perelman School of Medicine at the University of Pennsylvania. Some athletes are already…